STAT3 and lung adenocarcinoma: IL-11, a member of the IL-6 family, is upregulated in cisplatin-stimulated cancer-associated fibroblasts, and then IL-11 activates the STAT3 signaling pathway, leading to lung adenocarcinoma cell resistance to cisplatin [43].